The nation’s top osteoporosis researchers and clinicians will gather in Orlando, Florida this week for the National Osteoporosis Foundation’s (NOF) International Symposium on Osteoporosis (ISO12): Translating Research into Clinical Practice. Held annually, the meeting is the premier scientific event entirely dedicated to the treatment and study of osteoporosis and aims to close the gap between osteoporosis research and its application in clinical practice. As the 2012 recipient of the Lawrence G. Raisz, MD Memorial Lecture Award, Robert Lindsay, M.D., PhD, Chief of Internal Medicine at Helen Hayes Hospital, Past President and long-term NOF Board of Trustees member will present Skeletal Health in Osteoporosis: Past, Present & Future to kickoff the meeting’s opening session at 8:00am on Thursday, April 26.
Dr. Robert Lindsay to Kickoff NOF’s International Symposium on Osteoporosis (ISO12): Translating Research Into Clinical Practice Thursday, April 26 at the Peabody Hotel Orlando
Washington, D.C. April 24, 2012 – The nation’s top osteoporosis researchers and clinicians will gather in Orlando, Florida this week for the National Osteoporosis Foundation’s (NOF) International Symposium on Osteoporosis (ISO12): Translating Research into Clinical Practice. Held annually, the meeting is the premier scientific event entirely dedicated to the treatment and study of osteoporosis and aims to close the gap between osteoporosis research and its application in clinical practice.
As the 2012 recipient of the Lawrence G. Raisz, MD Memorial Lecture Award, Robert Lindsay, M.D., PhD, Chief of Internal Medicine at Helen Hayes Hospital, Past President and long-term NOF Board of Trustees member will present Skeletal Health in Osteoporosis: Past, Present & Future to kickoff the meeting’s opening session at 8:00am on Thursday, April 26. Dr. Lindsay will lead session participants on a journey from the early years of osteoporosis management when the only treatment available was estrogen and nearly all patients presented with fractures to the diagnostic and therapeutic advancements that have been made since and a preview of what’s to come.
“We are thrilled to have Dr. Lindsay open this year’s ISO with a look at the accomplishments we’ve made in better treating and diagnosing osteoporosis, but with osteoporosis causing an estimated two million fractures every year, we’re all focused on what’s to come as the condition remains significantly under-diagnosed and under-treated,” said Amy Porter, executive director and CEO, National Osteoporosis Foundation. “With the work researchers like Dr. Lindsay are doing every day, this is an exciting time in the osteoporosis field. Also as a top clinician, he embodies what we hope to accomplish through the ISO – that all attendees gain new information and insights they can apply in clinical practice to better treat and diagnose patients immediately following the conference.”
Named in honor of the late Lawrence G. Raisz, MD, the Lawrence G. Raisz, MD Memorial Lecture Award recognizes a clinical scientist who is dedicated to the prevention, diagnosis and treatment of osteoporosis and has made a significant contribution to the osteoporosis and bone metabolism field of study. As a longtime member of NOF’s Board of Trustees and the organization’s Vice President, Dr. Raisz’ service to NOF was extensive and invaluable.
He served as Chair of NOF’s first Scientific Advisory Board and subsequently was appointed a member of the Board of Trustees. While serving as NOF Vice President, Dr. Raisz chaired the Science and Research Committee and worked hard to raise awareness of osteoporosis and metabolic bone diseases among physicians and the public. His unwavering dedication to scientific excellence and patient care helped shape NOF's mission and programs of outreach and education. The investment Dr. Raisz made in the next generation of physician-scientists has helped ensure the continued growth and success of the osteoporosis and bone metabolism field.
Dr. Lindsay’s long-standing commitment to advancing osteoporosis care and treatment makes him a natural follower of the example set by Dr. Raisz and the leading choice to receive NOF’s prestigious award. Dr. Lindsay serves as the co-editor of NOF’s world class journal, Osteoporosis International and throughout his career, has authored more than 300 journal articles, abstracts, and book chapters on osteoporosis and estrogen replacement therapy. He was awarded the Bartter Award for excellence in clinical research in 1997 by the American Society for Bone and Mineral Research and was the recipient of NOF’s 1999 Scientific Leadership Award.
In addition to Dr. Lindsay’s opening session, ISO12 offers a comprehensive educational program covering all aspects of osteoporosis patient management, including innovative and cutting edge sessions presented by world class experts to help meet today’s clinical challenges. The pain and suffering caused by osteoporosis can be largely prevented through proper prevention, diagnosis and treatment. The information shared at ISO12 will provide clinicians with the most current data and practical application to prevent osteoporosis by more accurately identifying those at risk and better diagnosing and treating those with the disease.
About the National Osteoporosis Foundation
Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.